BRPI0418126A - método de diagnóstico sorológico e determinação de estatuto vacinal, compreendendo diferentes controles - Google Patents
método de diagnóstico sorológico e determinação de estatuto vacinal, compreendendo diferentes controlesInfo
- Publication number
- BRPI0418126A BRPI0418126A BRPI0418126-3A BRPI0418126A BRPI0418126A BR PI0418126 A BRPI0418126 A BR PI0418126A BR PI0418126 A BRPI0418126 A BR PI0418126A BR PI0418126 A BRPI0418126 A BR PI0418126A
- Authority
- BR
- Brazil
- Prior art keywords
- vaccine
- antigens
- control
- serological diagnosis
- determination
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 238000003745 diagnosis Methods 0.000 title abstract 2
- 230000000405 serological effect Effects 0.000 title abstract 2
- 239000000427 antigen Substances 0.000 abstract 4
- 102000036639 antigens Human genes 0.000 abstract 4
- 108091007433 antigens Proteins 0.000 abstract 4
- 230000003460 anti-nuclear Effects 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 238000010166 immunofluorescence Methods 0.000 abstract 1
- 230000000813 microbial effect Effects 0.000 abstract 1
- 230000009257 reactivity Effects 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 238000001179 sorption measurement Methods 0.000 abstract 1
- 229940043517 specific immunoglobulins Drugs 0.000 abstract 1
- 230000009897 systematic effect Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56938—Staphylococcus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Testing Of Engines (AREA)
Abstract
"MéTODO DE DIAGNóSTICO SOROLóGICO E DETERMINAçãO DE ESTATUTO VACINAL, COMPREENDENDO DIFERENTES CONTROLES". A presente invenção tem por objeto um método de diagnóstico sorológico por imunofluorescência indireta, compreendendo o controle sistemático da presença de fatores reumatóides e de anticorpos anti-nucleares em um soro de paciente, bem como o controle da presença e reatividade dos anticorpos secundários de detecção anti IgM e anti IgG utilizado. De acordo com a presente invenção, uma pluralidade de antígenos microbianos corpusculares e de antígenos de controle, que compreendem imunoglobulinas não específicas IgG e IgM e células nucleadas, são depositados por um robó e fixados por adsorção física sobre esse suporte sólido. A presente invenção se refere igualmente a um método de determinação do estatuto vacinal de um indivíduo por dosagem dos anticorpos de tipo IgG específicos de antígenos vacinais e isto para uma pluralidade de antígenos vacinais, segundo o método de diagnóstico, de acordo com a presente invenção.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0315327A FR2864624A1 (fr) | 2003-12-24 | 2003-12-24 | Methode de diagnostic serologique des maladies infectieuses par immunodetection d'antigene microbien comprenant le controle de reaction faussement positive ou negative |
| FR0408600A FR2874093B1 (fr) | 2004-08-03 | 2004-08-03 | Methode et trousse de determination du statut vaccinal de personnes |
| PCT/FR2004/003364 WO2005064340A2 (fr) | 2003-12-24 | 2004-12-23 | Methode de diagnostic serologique et determination de statut vaccinal comprenant differents controles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0418126A true BRPI0418126A (pt) | 2007-04-10 |
Family
ID=34740714
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0418126-3A BRPI0418126A (pt) | 2003-12-24 | 2004-12-23 | método de diagnóstico sorológico e determinação de estatuto vacinal, compreendendo diferentes controles |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20070160978A1 (pt) |
| EP (1) | EP1700128B1 (pt) |
| AT (1) | ATE439594T1 (pt) |
| BR (1) | BRPI0418126A (pt) |
| DE (1) | DE602004022588D1 (pt) |
| WO (1) | WO2005064340A2 (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102006027516B4 (de) * | 2006-06-09 | 2021-10-07 | Euroimmun Medizinische Labordiagnostika Ag | Verfahren zur Optimierung der automatischen Fluoreszenzmustererkennung in der Immundiagnostik |
| EP2089689A1 (en) * | 2006-11-29 | 2009-08-19 | Laboratorio Celsius S.A. | Method for analyzing image data relating to agglutination assays |
| FR2918459B1 (fr) * | 2007-07-04 | 2009-12-04 | Inodiag | Methode de diagnostic serologique multiplexe in vitro des infections a spirochetes |
| RU2472158C1 (ru) * | 2011-11-30 | 2013-01-10 | Федеральное государственное Бюджетное учреждение "Государственный научный центр дерматовенерологии и косметологии Министерства здравоохранения и социального развития Российской Федерации (ФГБУ "ГНЦДК" Минздравсоцразвития России) | Состав расширенной квалификационной панели контрольных материалов для осуществления внешнего и внутрилабораторного контроля качества серологической диагностики сифилитической инфекции |
| KR101341994B1 (ko) | 2012-02-20 | 2013-12-16 | 대한민국 | 간접면역형광항체법에 의한 레지오넬라증 진단용 항원슬라이드의 제조방법 및 이를 이용한 마이크로 다가 항원슬라이드 |
| CN102692502B (zh) * | 2012-04-26 | 2015-02-04 | 北京北方生物技术研究所 | 一种快速检测甲型肝炎病毒IgM抗体的试剂盒及其制备方法 |
| CN113567660A (zh) * | 2021-07-22 | 2021-10-29 | 中南大学湘雅二医院 | 一种检测系统性红斑狼疮患者自身抗体的方法 |
| CN120275649B (zh) * | 2025-06-11 | 2025-08-26 | 上海交通大学医学院附属仁济医院 | 一种适用于制备检测抗核抗体荧光免疫层析试纸条的Hep-2细胞提取物制备工艺及试纸条的制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DD301364A7 (de) * | 1990-04-19 | 1992-12-10 | Berlin Buch Klinikum | Verfahren zur Bestimmung von antinukleären Antikörpern |
| US5478753A (en) * | 1993-06-29 | 1995-12-26 | Pb Diagnostic Systems, Inc. | Positive calibrator/control composition for an IgM serology assay and an IgM serology assay |
| DE19731465A1 (de) * | 1997-07-22 | 1999-01-28 | Boehringer Mannheim Gmbh | Verwendung von Kontrollflächen zur Detektion von Störproben in einem Nachweisverfahren |
| EP0989406B1 (en) * | 1998-04-14 | 2008-05-14 | Otsuka Pharmaceutical Co., Ltd. | Methods for assaying antibody and device for assaying antibody |
| RU2213972C1 (ru) * | 2002-09-19 | 2003-10-10 | Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова РАМН | Способ определения состояния гуморального иммунитета к условно-патогенным бактериям одновременным выявлением igg антител |
-
2004
- 2004-12-23 WO PCT/FR2004/003364 patent/WO2005064340A2/fr not_active Ceased
- 2004-12-23 DE DE602004022588T patent/DE602004022588D1/de not_active Expired - Lifetime
- 2004-12-23 BR BRPI0418126-3A patent/BRPI0418126A/pt not_active IP Right Cessation
- 2004-12-23 EP EP04817587A patent/EP1700128B1/fr not_active Expired - Lifetime
- 2004-12-23 US US10/583,771 patent/US20070160978A1/en not_active Abandoned
- 2004-12-23 AT AT04817587T patent/ATE439594T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE439594T1 (de) | 2009-08-15 |
| EP1700128A2 (fr) | 2006-09-13 |
| EP1700128B1 (fr) | 2009-08-12 |
| DE602004022588D1 (de) | 2009-09-24 |
| WO2005064340A2 (fr) | 2005-07-14 |
| WO2005064340A3 (fr) | 2005-11-24 |
| US20070160978A1 (en) | 2007-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20220373T1 (hr) | POSTUPAK I REAGENSI ZA DIJAGNOZU SARS-CoV-2 | |
| Zhu et al. | A microdevice for multiplexed detection of T-cell-secreted cytokines | |
| Howard et al. | Basic methods in antibody production and characterization | |
| Hober et al. | Systematic evaluation of SARS‐CoV‐2 antigens enables a highly specific and sensitive multiplex serological COVID‐19 assay | |
| BRPI0418126A (pt) | método de diagnóstico sorológico e determinação de estatuto vacinal, compreendendo diferentes controles | |
| McDowell et al. | Evidence that the BBA68 protein (BbCRASP-1) of the Lyme disease spirochetes does not contribute to factor H-mediated immune evasion in humans and other animals | |
| Malik et al. | Antibody techniques | |
| CN102965343A (zh) | 分泌牛γ干扰素单克隆抗体的杂交瘤细胞株、其单克隆抗体及其应用 | |
| DE59209079D1 (de) | Monoklonale Antikörper gegen humane Pankreas-Inselzellen | |
| Day | Introduction to antigen and antibody assays | |
| Brocchi et al. | Development of two novel monoclonal antibody-based ELISAs for the detection of antibodies and the identification of swine isotypes against swine vesicular disease virus | |
| Lundgren et al. | Plasmablasts in previously immunologically naïve COVID-19 patients express markers indicating mucosal homing and secrete antibodies cross-reacting with SARS-CoV-2 variants and other beta-coronaviruses | |
| ATE66532T1 (de) | Reagenz fuer den nachweis von nicht-a-nicht-bviraler hepatitis und verfahren zur diagnose von solcher hepatitis auf immunoenzymatischem wege. | |
| Alberú et al. | A non-allogeneic stimulus triggers the production of de novo HLA antibodies in healthy adults | |
| Richalet-Sécordel et al. | Uses of biosensor technology in the development of probes for viral diagnosis | |
| Hart et al. | Falsely incompatible B-cell flow cytometry crossmatch after pronase treatment: a case report | |
| Hayashi et al. | Elevated mycobacterium avium subsp. paratuberculosis (MAP) antibody titer in Japanese multiple sclerosis | |
| WO2019194360A8 (ko) | 개의 수혈 적합성 판별 방법, 및 이를 위한 키트, 단일클론항체 및 하이브리도마 세포주 | |
| Gürtürk et al. | Detection of Campylobacter Antibodies in Sheep Sera by a Dot‐ELISA Using Acid Extracts from C. fetus ssp. fetus and C. jejuni Strains and Comparison with a Complement Fixation Test | |
| JP2002306164A (ja) | エボラウイルスを認識するモノクローナル抗体 | |
| Kalkeri et al. | P-1972. SARS-CoV-2 Vaccine–Induced IgG4 Response Negatively Correlates with Neutralizing Antibodies and Fc Effector Functions | |
| Helbig et al. | Common epitope on urinary antigen derived from different Legionella pneumophila serogroup 1 strains recognized by a monoclonal antibody | |
| Boyko et al. | Detection of Cholera Toxin in Culture Medium by Dot-Immunoassay on Dipsticks | |
| Crouzillac et al. | Targeting intestinal microbiota with Bifidobacterium breve and Hafnia alvei probiotics does not improve response to influenza vaccine in mice | |
| Jagwan et al. | Preparation and Purification of Monoclonal Antibody against Hepatitis B Surface Antigen (HBsAg) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012. |